HeartSciences Inc. (HSCS) shareholders
Close on Nov 17, 2026Market cap $9.89MP/E –Yield 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Matthews Holdings Southwest Inc. Joint filing with John H. Matthews (8.10%) | 5,241,758 | 8.10% | 13G (passive) | Nov 15, 2023 |
| Icahn School Of Medicine At Mount Sinai ("ismms") | 4,854,853 | 9.90% | 13G (passive) | Nov 16, 2023 |
| Fortitude Mining Holdings, Inc. Joint filing with Digital Currency Group, Inc. (9.40%) | 411,522 | 9.40% | 13D (active) | Aug 12, 2026 |
| Andrew Simpson | 403,739 | 7.50% | 13D (active) amendment | Oct 5, 2026 |
| Press, Philip H Joint filing with Wlezien Alexander M. (6.02%) | 299,271 | 6.02% | 13G (passive) | Oct 21, 2026 |
| Fields Ephraim G | 265,218 | 8.10% | 13G (passive) | Jun 23, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HSCS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| TFB Advisors LLC | 29,740 | – | $74.65K | – | 0.03% |
| Geode Capital Management, LLC | 23,049 | – | $57.85K | −5,889 | 0.00% |
| Astoria Strategic Wealth, Inc. | 18,927 | – | $47.51K | – | 0.01% |
| Vanguard Capital Management LLC | 17,968 | – | $45.10K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 17,239 | – | $43.27K | – | 0.00% |
| Tradition Wealth Management, LLC | 16,819 | – | $42.22K | – | 0.00% |
| Citadel Advisors LLC | 14,488 | – | $36.37K | New | 0.00% |
| Citigroup Inc | 5,859 | – | $14.71K | New | 0.00% |
| UBS Group AG | 5,812 | – | $14.59K | −664 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,568 | – | $3.94K | −483 | 0.00% |
| BlackRock, Inc. | 750 | – | $1.88K | New | 0.00% |
| Federation des caisses Desjardins du Quebec | 700 | – | $1.76K | – | 0.00% |
| Osaic Holdings, Inc. | 650 | – | $1.63K | +600 | 0.00% |
| Allied Private Wealth LLC | 120 | – | $327 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 8 | – | $20 | New | 0.00% |
| Financial Management Professionals, Inc. | 2 | – | $5 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 6 / 1 | 3 / 3 | 0M | 0M |
| Q1 2026 | 13 | 0M | 5 / 3 | 1 / 1 | 0M | 0M |
| Q4 2025 | 10 | 0M | 1 / 4 | 0 / 3 | 0M | 0M |
| Q3 2025 | 12 | 0M | 6 / 4 | 1 / 1 | 0M | 0M |
| Q2 2025 | 7 | 0M | 4 / 1 | 1 / 2 | 0M | 0M |
| Q1 2025 | 5 | 0M | 2 / 3 | 0 / 0 | 0M | 0M |
| Q4 2024 | 3 | 0M | 0 / 2 | 1 / 3 | 0M | 0M |
| Q3 2024 | 6 | 0M | 1 / 2 | 2 / 2 | 0M | 0M |
| Q2 2024 | 7 | 0M | 7 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held HSCS in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HSCS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 19,367 | – | $32.15K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 17,968 | – | $45.10K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 2,693 | – | $4.47K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 2,249 | – | $3.73K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Andrew Simpson | See Remarks, Director | 499,382 | Jun 24, 2026 |
| Danielle Watson | See Remarks | – | Jul 9, 2026 |
| Mark T. Hilz | See Remarks | 4,793 | Dec 22, 2025 |
| David R. Wells | Director | – | Jan 12, 2026 |
| Bruce Bent | Director | 1,638 | Jan 12, 2026 |
| Brian Szymczak | Director | 6,060 | Dec 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Andrew Simpson See Remarks, Director | Jun 22, 2026 | Award | +425,000 | – | – | 499,382 |
| Andrew Simpson See Remarks, Director | Nov 28, 2025 | Award | +70,000 | – | – | 74,382 |
| Mark T. Hilz COO, Secretary and Director | Jul 29, 2025 | Sale(10b5-1 plan) | −4,416 | $3.54 | $15.63K | 4,752 |
| Andrew Simpson See Remarks, Director | Aug 12, 2024 | Other | +17 | – | – | 7,629 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of HeartSciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,607 shares on Oct 7, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Mark T. Hilz Officer, Director | Jul 29, 2025 | 4,416 | $15.72K | Jul 29, 2025 | PURCHASE |
See a number that looks wrong?